Efficacy of Combination Therapy With Radium-223 and Enzalutamide in Castration-resistant Prostate Cancer With Bone Metastases
Anticancer Research · 2024
DOI: 10.21873/anticanres.17069 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Naoto Wakita und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan complus_duefl@yahoo.co.jp. Hauptthemen laut MEDLINE: Phenylthiohydantoin, Benzamides, Nitriles, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan complus_duefl@yahoo.co.jp.
- Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
Zitieren
APA
Wakita, N., Hara, T., Suzuki, K., Terakawa, T., Teishima, J., Nakano, Y., & Miyake, H. (2024). Efficacy of Combination Therapy With Radium-223 and Enzalutamide in Castration-resistant Prostate Cancer With Bone Metastases. Anticancer Research. https://doi.org/10.21873/anticanres.17069
Vancouver
Wakita N, Hara T, Suzuki K, Terakawa T, Teishima J, Nakano Y, et al. Efficacy of Combination Therapy With Radium-223 and Enzalutamide in Castration-resistant Prostate Cancer With Bone Metastases. Anticancer Research. 2024. doi:10.21873/anticanres.17069
BibTeX
@article{Wakita2024,
author = {Wakita, Naoto and Hara, Takuto and Suzuki, Kotaro and Terakawa, Tomoaki and Teishima, Jun and Nakano, Yuzo and Miyake, Hideaki},
title = {Efficacy of Combination Therapy With Radium-223 and Enzalutamide in Castration-resistant Prostate Cancer With Bone Metastases},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17069}
}
EUVIMED